Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT ® Autoinjector: A Prospective Observational Cohort Study
Conclusions: Compliance with IFNβ-1b treatment among participants still under observation remained high over a 24-month period, while persistence and adherence continuously declined. Multiple factors affected medication-taking behavior, including patient characteristics, treatment history, injection site reactions, patients' perception of their health and support programs. The importance of these factors may differ among patients according to their individual situation.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Brain | Germany Health | Multiple Sclerosis | Neurology | Nutrition | Pain | Study | Vitamin D | Vitamins